These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6102457)

  • 1. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects.
    Tune L; Coyle JT
    Arch Gen Psychiatry; 1980 Mar; 37(3):293-7. PubMed ID: 6102457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute extrapyramidal side effects: serum levels of neuroleptics and anticholinergics.
    Tune L; Coyle JT
    Psychopharmacology (Berl); 1981; 75(1):9-15. PubMed ID: 6117922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.
    Gibson RE; Eckelman WC; Vieras F; Reba RC
    J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone.
    Tracy JI; Monaco CA; Abraham G; Josiassen RC; Pollock BG
    J Clin Psychiatry; 1998 Apr; 59(4):184-8. PubMed ID: 9590669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptors in rat uterus.
    Pennefather JN; Gillman TA; Mitchelson F
    Eur J Pharmacol; 1994 Sep; 262(3):297-300. PubMed ID: 7813596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomalous binding of [3H]N-methyl-quinuclidinyl benzilate methyl chloride to human lymphocyte muscarinic receptors.
    Usami K; Kaku Y
    Life Sci; 1992; 51(8):PL67-71. PubMed ID: 1640803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.
    Katayama S; Ishizaki F; Yamamura Y; Khoriyama T; Kito S
    Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):261-70. PubMed ID: 2236897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic activity in the serum of patients receiving maintenance amitriptyline or doxepin therapy.
    Aaltonen L; Syvälahti E; Iisalo E; Peltomäki T
    Acta Pharmacol Toxicol (Copenh); 1985 Jan; 56(1):75-80. PubMed ID: 3976405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cognitive toxicity of anticholinergic drugs.
    Katz IR; Greenberg WM; Barr GA; Garbarino C; Buckley P; Smith D
    J Clin Psychiatry; 1985 Aug; 46(8):323-6. PubMed ID: 2862135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radio receptor assay of serum neuroleptic levels in psychiatric patients.
    Krska J; Sampath G; Shah A; Soni SD
    Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
    Bylund DB
    J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug levels and antiparkinsonian drugs in neuroleptic-treated schizophrenic patients.
    Hitri A; Craft RB; Sethi R; Sinha D
    Clin Neuropharmacol; 1987 Jun; 10(3):261-71. PubMed ID: 2900683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the low incidence of extrapyramidal side-effects of antipsychotics associated with antimuscarinic properties?
    Laduron PM; Leysen JE
    J Pharm Pharmacol; 1978 Feb; 30(2):120-2. PubMed ID: 24098
    [No Abstract]   [Full Text] [Related]  

  • 15. Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia.
    Yamamura HI; Watson M; Wamsley JK; Johnson PC; Roeske WR
    Life Sci; 1984 Aug; 35(7):753-7. PubMed ID: 6547993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
    Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
    Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on the affinities of various muscarinic antagonists to the human detrusor muscle].
    Kondo S; Morita T; Hirano S
    J Smooth Muscle Res; 1993 Apr; 29(2):63-8. PubMed ID: 8318731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors.
    Christopoulos A; Wilson K
    Brain Res; 2001 Oct; 915(1):70-8. PubMed ID: 11578621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.